JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $69,400 | -98.1% | 37,513 | -98.9% | 0.00% | – |
| Q4 2022 | $3,637,135 | +13370.9% | 3,276,699 | +28358.4% | 0.00% | – |
| Q3 2022 | $27,000 | 0.0% | 11,514 | +30.9% | 0.00% | – |
| Q2 2022 | $27,000 | -91.7% | 8,796 | -81.7% | 0.00% | – |
| Q1 2022 | $327,000 | -36.1% | 48,099 | -21.5% | 0.00% | – |
| Q4 2021 | $512,000 | +642.0% | 61,292 | +558.8% | 0.00% | – |
| Q3 2021 | $69,000 | -23.3% | 9,303 | -29.6% | 0.00% | – |
| Q2 2021 | $90,000 | -71.0% | 13,222 | -56.2% | 0.00% | – |
| Q1 2021 | $310,000 | +638.1% | 30,161 | +401.4% | 0.00% | – |
| Q4 2020 | $42,000 | -40.0% | 6,015 | -29.9% | 0.00% | – |
| Q3 2020 | $70,000 | -5.4% | 8,584 | -20.2% | 0.00% | – |
| Q2 2020 | $74,000 | +32.1% | 10,754 | -8.9% | 0.00% | – |
| Q1 2020 | $56,000 | -17.6% | 11,806 | +52.7% | 0.00% | – |
| Q4 2019 | $68,000 | -39.8% | 7,733 | -77.3% | 0.00% | – |
| Q3 2019 | $113,000 | -41.8% | 34,129 | -13.0% | 0.00% | – |
| Q2 2019 | $194,000 | +0.5% | 39,242 | +26.1% | 0.00% | – |
| Q1 2019 | $193,000 | +63.6% | 31,108 | -11.3% | 0.00% | – |
| Q4 2018 | $118,000 | -28.9% | 35,082 | +37.4% | 0.00% | – |
| Q3 2018 | $166,000 | -24.2% | 25,538 | -10.7% | 0.00% | – |
| Q2 2018 | $219,000 | +17.1% | 28,607 | +243.4% | 0.00% | – |
| Q1 2018 | $187,000 | +88.9% | 8,331 | +7.4% | 0.00% | – |
| Q4 2017 | $99,000 | +86.8% | 7,758 | +128.2% | 0.00% | – |
| Q3 2017 | $53,000 | +76.7% | 3,400 | +55.1% | 0.00% | – |
| Q2 2017 | $30,000 | +15.4% | 2,192 | +88.6% | 0.00% | – |
| Q1 2017 | $26,000 | – | 1,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |